Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 429

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 429
---
idity, Capital Resources and Going Concern As of September30, 2024, we had cash outside our Trust Account of $7,555 available for working capital needs. All remaining cash was held in the Trust Account and is generally unavailable for our use prior to our initial Business Combination. For the nine months ended September30, 2024, we used $743,940 in operating activities, which was largely driven by $1,246,905 in interest earned on our investments held in the Trust Account offset by $95,191 in net income and a $407,774 change in operating assets and liabilities. For the nine months ended September30, 2024, we were provided $26,320,476 in our investing activities, which was driven by $26,907,976 in shareholder redemptions offset by $587,500 in extension contributions. For the nine months ended September30, 2024, we used $25,569,018 in our financing activities, which was the largely the result of $26,907,976 paid out in redemptions to shareholders offset by $1,338,958 in proceeds from our promissory notes. For the year ended December31, 2023, we used $786,645 in operating activities, which was largely driven by $4,486,207 in interest earned on our investments held in the Trust Account offset by $2,494,909 in net income as well as changes in prepaid expenses of $277,113, accounts payable and accrued expenses of $912,404 and due to related party of $15,136. For the year ended December31, 2023, we were provided $131,816,922 from our investing activities, which was driven by $132,616,922 redemptions as a result of our extraordinary shareholder meeting offset by $800,000 in Extension contributions. For the year ended December31, 2023, we utilized $131,274,419 in our financing activities, which was the result of the $132,616,922 payout of redemptions by our shareholders offset by $1,342,503 in proceeds from our promissory notes. As noted above, pursuant to our Initial Public Offering on November8, 2021 and the full exercise of the over -allotmentoption on November12, 2021, we sold 17,250,000 Units at a price of $10.00 per Unit, generating gross proceeds to us of $172,500,000.